Tyme Investor Relations Material
Latest events
Q3 2022
Tyme
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Tyme Technologies Inc
Access all reports
Tyme Technologies Inc was a biotechnology company that developed cancer metabolism-based therapies aimed at targeting and disrupting cancer cell metabolism. The company focused on developing novel therapeutic candidates for the treatment of various types of cancer. Tyme Technologies served the oncology sector through research-driven initiatives. The company was headquartered in Bedminster, New Jersey, and its shares were listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
TYME
Country
🇺🇸 United States